Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%

Corcept Therapeutics Incorporated (CORT)

-NasdaqCM
3.62 Apr 16, 4:00PM EDT
Get the big picture on all your investments.
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):3.0
Mean Recommendation (last week):3.1
Change:-0.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:3.50
Median Target:2.00
High Target:8.00
Low Target:1.50
No. of Brokers:5

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jan 13, 2014StifelDowngradeBuyHold
Aug 9, 2013Ladenburg ThalmannDowngradeBuyNeutral
Aug 9, 2013JanneyDowngradeBuyNeutral
Aug 19, 2010Global HunterInitiated Buy
Jan 6, 2010Ladenburg ThalmannUpgradeNeutralBuy
Jul 17, 2008Rodman & RenshawInitiated Mkt Outperform
Feb 19, 2008Thomas WeiselUpgradeMarket WeightOverweight
Jun 21, 2007Punk, Ziegel & CoUpgradeMkt PerformAccumulate
Aug 28, 2006Punk, Ziegel & CoDowngradeBuyMkt Perform
Aug 25, 2006Merriman Curhan FordDowngradeBuyNeutral

More Upgrades & Downgrades for CORT

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0001
Buy0000
Hold6776
Underperform1111
Sell0000

Data provided by Thomson/First Call


Currency in USD.